Tag results:

pancreatic cancer

Integrated Systems-Analysis of the Murine and Human Pancreatic Cancer Glycomes Reveal a Tumor Promoting Role for ST6GAL1

[Molecular & Cellular Proteomics] Researchers observed both common and distinct patterns of glycosylation in pancreatic cancer across species. Common alterations included increased levels of Ī±-2,3- and Ī±-2,6-sialic acids, bisecting GlcNAc and poly-LacNAc.

SNAIL2 Contributes to Tumorigenicity and Chemotherapy Resistance in Pancreatic Cancer by Regulating IGFBP2

[Cancer Science] Scientists showed that the suppression of SNAIL2 expression using RNA interference decreased tumorigenicity in vitro and in vivo in two pancreatic cancer cell lines, KLM1 and KMP5.

Propofol Mediates Pancreatic Cancer Cell Activity through the Repression of ADAM8 via SP1

[Oncology Reports] Researchers focused upon the effect of propofol on pancreatic cancer cells and the mechanism by which propofol reduced A disintegrin and metalloproteinase 8 (ADAM8) expression.

Cholesterol Biosynthesis Inhibitor RO 48ā€“8071 Inhibits Pancreatic Ductal Adenocarcinoma Cell Viability by Deactivating the JNK and ERK/MAPK Signaling Pathway

[Molecular Medicine Reports] RO 48ā€‘8071 (RO) was used to treat the pancreatic cancer cell line in vitro to examine the effects of RO on cell viability, as well as to determine its potential molecular mechanism.

SETD8 Induces Stemness and Epithelialā€“Mesenchymal Transition of Pancreatic Cancer Cells by Regulating ROR1 Expression

[Acta Biochimica Et Biophysica Sinica] SETD8 mediated receptor tyrosine kinase-like orphan receptor 1 (ROR1) activity and regulated pancreatic cancer cells invasion and migration, although promoting the expression of stemness and epithelialā€“mesenchymal transition-related molecules.

A 584 BP Deletion in CTRB2 Inhibits Chymotrypsin B2 Activity and Secretion and Confers Risk of Pancreatic Cancer

[American Journal of Human Genetics] Scientists proposed that intracellular accumulation of a nonfunctional chymotrypsinogen B2 protein led to endoplasmic reticulum stress and pancreatic inflammation, which might explain the increased pancreatic cancer risk in carriers of CTRB2 exon 6 deletion alleles.

Popular